MedPath
NMPA Approval

Pertuzumab Injection

国药准字S20240053

December 17, 2024

Drug Information

帕妥珠单抗注射液

安赛珠

注射剂

420mg(14ml)/瓶

生物制品

December 17, 2024

Company Information

Applicant Company

山东省济南市高新区新泺大街317号

Manufacturing Company

山东省济南市高新区旅游路8888号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

帕妥珠单抗注射液 - NMPA 批准文号 | MedPath